Concepedia

Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trial

Rebecca Jane Cox, Gabriel Kristian Pedersen, Abdullah S. Madhun, Signe Svindland, Marianne Sævik, Lucy Breakwell, Katja Höschler, Marieke Willemsen, Laura Campitelli, Jane Kristin Nøstbakken,

Vaccine · 2011 · 102 citations · 31 references

DOI

Concepts

References

31

Detection of Antibody to Avian Influenza A (H5N1) Virus in Human Serum by Using a Combination of Serologic Assays

Thomas Rowe, Robert A. Abernathy, Jean Hu‐Primmer et al. · Journal of Clinical Microbiology · 1999 · 814 citations · Full text

, , +13

Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) Vaccine

John J. Treanor, James D. Campbell, Kenneth M. Zangwill et al. · New England Journal of Medicine · 2006 · 704 citations · Full text

, , +17

Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial

Isabel Leroux‐Roels, Astrid Borkowski, Thomas Vanwolleghem et al. · The Lancet · 2007 · 503 citations

, , +14

Response to a Monovalent 2009 Influenza A (H1N1) Vaccine

Michael E. Greenberg, Michael H. Lai, Günter Härtel et al. · New England Journal of Medicine · 2009 · 494 citations · Full text

, , +11

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza

Karl G. Nicholson, Anthony Colegate, Audino Podda et al. · The Lancet · 2001 · 444 citations

, , +16